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Many paramyxoviruses appear to require cytoskeletal elements for particular steps in the virus life cycle. Measles virus and Sendai virus
exhibit a requirement for microtubules in replication in vitro, whereas parainfluenza virus type 3 and RSV require actin for replication. To
further elucidate the role of cytoskeletal function and rearrangement in the viral life cycle of RSV, we investigated the efficiency of virus
entry, transcription, replication, and budding in the presence of a variety of pharmacological agents that stabilize or depolymerize actin or
microtubules. We found that alteration of microtubule or actin function resulted in blocks at entry, formation of cell-associated virus, virus
release, local cell-to-cell spread, and syncytium formation. Actin and microtubules act in cooperation to facilitate replication of RSV,
although microtubules play a dominant role in the formation of cell-associated virus while actin plays a more prominent role in virus release.
D 2004 Elsevier Inc. All rights reserved.
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Respiratory syncytial virus (RSV) is a member of the
paramyxovirae family and the leading cause of viral lower
respiratory disease in infants and young children. The virus
contains a single-stranded, negative-sense RNA genome
that encodes 11 proteins. A better understanding of the virus
life cycle and the interactions of RSV with its host cell
environment is needed to facilitate studies of viral patho-
genesis, and the development of antiviral or immunother-
apeutic interventions.
Viruses use the host cell machinery to facilitate entry,
replication, transport, and release of progeny virions. The
intricate structural system that is referred to as the
cytoskeletal network is composed of actin, microtubules,0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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microtubules form the majority of the cytoskeletal frame-
work of the cell and provide the infrastructure for major
trafficking pathways of cellular proteins and vesicles. Actin
is present in non-muscle cells in a globular monomeric form
(G-actin), and in a filamentous form (F-actin) that con-
stitutes the polymerized microfilament. Actin microfila-
ments are in a dynamic state characterized by rapid cycles of
polymerization/depolymerization that occur in response to
varying stimuli (Wear et al., 2000). The other major
constituent of the cytoskeleton is the microtubule network,
which is made of polymerized a- and h-tubulin. Micro-
tubules achieve highly ordered structures that exhibit an
intrinsic polarity. These filaments contribute to the stability
and shape of cells, and determine the pathways of vesicle
and protein trafficking within the cell with the help of motor
proteins (Hunter and Wordeman, 2000). We have previously
shown that the actin motor myosin Vb regulates directional
budding of RSV in polarized epithelial cells (Brock et al.,
2003). Recent studies of viral interactions with cellular
processes suggest that different viruses use different005) 73–81
Table 1
Cytoskeletal inhibitors used in this study and their mode of action
Cytoskeletal
target
Inhibitor Concentration
used in study
Mode of action
N.L. Kallewaard et al. / Virology 331 (2005) 73–8174elements of the cytoskeleton for entry, transport of viral
proteins, function of replication machinery inside the cell,
and for viral release (Cudmore et al., 1997; Sodeik, 2000).
Previous investigators showed that some members of the
paramyxovirus family interact directly with the cytoskele-
ton. Measles virus and Sendai virus require microtubules for
efficient replication in vitro, while parainfluenza virus type
3 and RSV replication require actin in vitro (Burke et al.,
1998; De et al., 1991; Hill et al., 1986). Experiments using
RSV suggest that this pneumovirus requires actin in either
filamentous or monomeric form together with the actin
cofactor profilin for optimal replication in vitro (Burke et
al., 2000). While these biochemical experiments suggest a
role for actin in RSV replication, the significance of such
interactions in living cells is unknown. Actin has been found
within the virion particle of RSVand other paramyxoviruses
after release from cells, which suggests a possible role for
actin in the release of virions from the cell (Fernie and
Gerin, 1982; Stallcup et al., 1979; Tyrrell and Norrby,
1978). Actin has also been shown to play a role in the
morphology of cell-associated filamentous virus (Roberts
and Compans, 1998; Yao and Compans, 2000). More
detailed information is needed about these processes and
the role of the cytoskeleton in other life cycle steps of RSV.
We used a panel of chemical inhibitors that interfere with
the normal polymerization or depolymerization states of
microfilaments or microtubules to study the role of the
cytoskeleton in the RSV life cycle. Previous studies
investigated the effect of cytochalasin D and nocodazole
on virus replication (Burke et al., 1998). The recent
development of additional actin and microtubule inhibitors
allows for more defined studies of virus/cytoskeletal
interactions (Spector et al., 1999). We sought to determine
whether RSV replication in cells requires proper function of
microtubules or actin, and if so, to determine the stage of the
virus life cycle during which those requirements were most
evident. We found that alteration of either type of major
cytoskeletal elements significantly affected each step of the
RSV life cycle examined, except for viral genomic
replication and transcription. Our experiments also suggest
that microtubules play a dominant role during processes that
result in the production of cell-associated infectious virus,
while actin filaments exert a greater effect on egress of virus
from the cell.
Actin Latrunculin A 500 nM Binds to monomeric
(G) actin and disrupts
polymerization
Cytochalasin D 4 AM Binds to filamentous
(F) actin and disrupts
polymerization
Jasplakinolide 1 AM Binds to filamentous
(F) actin and stabilizes
Microtubules Nocodazole 17 AM Binds to h-tubulin and
prevents interchain bonds
Paclitaxel 25 AM Binds to N-terminus
of h-tubulin and
promotes formation of
highly stable microtubulesResults
Proper function of both microtubules and actin is required
for entry and early replication events
In order to determine if proper function of the cytoske-
leton is required for entry and early steps of RSV
replication, we treated cells with a panel of cytoskeletal
inhibitors. We selected inhibitors that function in stabiliza-
tion or destabilization of either microtubules or actin. Weused each inhibitor at a concentration determined by
preliminary experiments that mediated highest activity with
a minimal amount of cell death (data not shown). The
mechanism of action of the inhibitors along with the
concentration of each inhibitor that was used in these
studies is shown in Table 1. Inhibitors were added to cells
either 3, 6, or 12 h prior to virus adsorption or added only
after viral absorption, as indicated in Table 2. An RSV strain
with the GFP gene incorporated within the virus genome
was used so that live virus-infected cells could be visualized
and counted by GFP expression and the morphology of
infectious foci could be followed throughout the virus life
cycle (Hallak et al., 2000). These experiments allowed us to
determine the effect of inhibitors on viral entry and early
replication, on local cell-to-cell spread, and on syncytium
formation caused by cell-to-cell fusion, which are hallmarks
of RSV infection in culture. Cells were visualized at 14 h
post-infection and fluorescence focus units (ffu) represent-
ing successful virus entry and early replication events were
counted. The resulting virus titer was expressed as log10 ffu/
ml (Table 2). We found that cell cultures that were exposed
to the inhibitors before virus entry showed a significant
reduction in ffu compared to the control cells that were
treated only after viral absorption. Significant reductions of
RSV infectious foci were mediated by the cytoskeletal
inhibitors latrunculin A, cytocholasin D, and jasplakinolide,
which each caused a 5- to 10-fold reduction in viral ffu titer.
This inhibition was observed at the earliest time point (3-h
pretreatment during cytochalasin D treatment). This finding
was in concordance with the rapid change in morphology
caused by these cytoskeletal inhibitors. The microtubule
inhibitors nocodazole and taxol caused a reduction of virus
of 9-fold and 3-fold, respectively by 12 h. The magnitude of
the reduction caused by the microtubule inhibitors gradually
increased with time. This finding is consistent with the
relatively slow kinetics of action of these inhibitors, which
do not cause striking changes in cellular morphology until
the longer preincubation periods.
Table 2
Replication of RSV in cells treated with cytoskeletal inhibitors applied before or after virus adsorption
Treatment Mean virus titera when inhibitor was present during indicated
stage in experimental infection
Fold reduction mediated by pre-treatmentb
Post-adsorption Pre-treatment
3 h 6 h 12 h
3 h 6 h 12 h
Solvent only 5.7 5.6 5.7 5.6 b2 b2 b2
Actin inhibitors
Latrunculin A 5.4 4.9 5.0 4.6 3 2 6
Cytochalasin D 5.8 4.9 4.9 4.8 9 9 10
Jasplakinolide 5.2 4.9 4.7 4.5 2 3 5
Microtubule inhibitors
Nocodazole 5.9 5.5 5.3 4.8 2 3 9
Paclitaxel 5.8 5.8 5.5 5.4 b2 2 3
a Results shown are the mean values for six separate infected culture wells. Values indicate log10 fluorescent focus units (ffu) per milliliter.
b Fold reduction was calculated by comparing mean titer for cells treated before and after virus adsorption with the titer of wells without pre-treatment, i.e., the
values shown in the bpost-adsorptionQ column.
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the release and assembly of RSV
Inhibitor treatments after virus absorption did not mediate
a significant reduction in the number of infectious foci of
RSV compared to solvent alone (Table 2). This finding al-
lowed us to study the role of the cytoskeleton in the viral life
cycle steps after entry and early replication. We determined
the effect of each of the inhibitors on the later stages in RSV
replication by adsorbing virus at either a low or high M.O.I.
followed by the addition of the inhibitors. To differentiate
between effects on distinct viral processes such as assembly
of cell-associated virus and budding of virions from the cell,
we collected the cell fraction and supernatant separately
during the course of viral infection for 3 days. After all
experiments were completed, the amount of virus present in
each fraction was quantitated by virus plaque assay. The
results are shown in Fig. 1. In panels A and C, data for the
virus collected in the supernatant following infection at either
a high (Fig. 1A) or low (Fig. 1C) M.O.I. is shown. Each
inhibitor caused a 10- to 100-fold inhibition of viral titer in
the released pool of virus. Some of the inhibitors mediated a
rapid inhibition that was apparent by the reduction of virus
titer even on the first day post-infection. The amount of re-
duction increased significantly on day 2 and 3 post-infection,
with the latter inhibition being the greatest. This pattern of
inhibition was observed for all cytoskeletal inhibitors, and
was seen in both the high and low M.O.I. experiments. At a
highM.O.I., viral spread is not necessary within the culture to
achieve a productive infection of each cell. The inhibition we
observed in these experiments was likely due to a block in
release of virus because an inhibition was observed in both
the high and low M.O.I. conditions. Although each of the
agents mediated an inhibition, interesting differences were
observed in the amount of viral reductions. The actin
inhibitors cytochalasin D and jasplakinolide showed the
greatest effect on virus release, each mediating a 1000-fold
reduction on day 3 of the high M.O.I. experiments and even
higher reductions in the low M.O.I. experiments.We also examined the amount of virus present in the cell-
associated fraction from these samples. As shown in panels
B and D of Fig. 1, the inhibitors mediated only a minor
reduction in the titer of cell-associated virus, in contrast to
the large effect on released virus. The actin inhibitor
latrunculin A had little if any effect on cell-associated viral
production in the high M.O.I. reduction experiments (Fig.
1B). The microtubule inhibitors nocodazole and paclitaxel
mediated the greatest reduction in viral growth in the cell-
associated fraction. The inhibition caused by these agents in
the high M.O.I. studies could be distinguished from the
effects of other inhibitors on day 2 (over a 10-fold
reduction), but by day 3 the reduction was no longer
apparent in the single round of infection studies. The results
of the low M.O.I. cell-associated studies (Fig. 1D) show a
modest decrease in virus production caused by each of the
inhibitors. Since the low M.O.I. experiments represent a
situation in which the virus must spread in the culture from
cell to cell for optimal yields, the inhibition seen under these
conditions reflects a combination of the modest reduction
seen in the cell-associated fraction and the large inhibitory
effect on the release of virus. These results suggest that
microtubule inhibitors reduced both the total amount of
virus produced in the cell and the amount of virus that was
allowed to egress from cells.
Microtubules mediate a greater effect on viral assembly,
whereas actin filaments play a dominant role in the release
of virus
The data from the inhibition studies above showed that
two of the actin inhibitors mediated the greatest reduction
on the released virus, and two of the microtubule inhibitors
mediated the greatest effect on the cell-associated virus. To
analyze whether these effects could be generalized, we
measured the reduction (log10 pfu/ml) on day 2 for each
inhibitor under all four conditions and calculated the ratio of
reduction in the released virus versus the reduction in the
cell-associated virus. A graphical representation of these
Fig. 1. The effect of the cytoskeletal inhibitors on RSV replication after entry. HEp-2 cell monolayer cultures were infected with either a high M.O.I. of 8 (A, B)
or a low M.O.I. of 0.3 (C, D). Inhibitors were added after adsorption, and supernatant and cell fraction were collected each day. Viral titer of each sample was
determined in duplicate by virus plaque assay, end point titers were calculated as log10 pfu/ml and the mean and standard deviation of the reduction is shown.
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represents an equivalent effect of the inhibitor on virus
release and cell-associated virus production, a value greater
than 1 represents a situation where the inhibitor had a
greater effect on the release of virus, and a value less than 1
represents inhibitors that had a greater effect on the
formation of cell-associated virus. The ratio of inhibitionFig. 2. Mechanism of RSV inhibition of the actin and microtubule
inhibitors. The ratio of the log10 pfu/ml reduction in the supernatant to
the amount of reduction in the cell-associated fraction is shown for each
inhibitor on day 2 at both lo (M.O.I. = 0.3) or hi (M.O.I. = 8) conditions.
Experiments using actin inhibitors are shown in the striped bars; those using
microtubule inhibitors are shown in the solid bars. Inhibitors are indicated
by the following abbreviations: Lat = latrunculin A, Cyt = cytochalasin D,
Jas = jasplakinolide, Noc = nocodazole, and Pac = paclitaxel.of all of the actin inhibitors grouped together with values
above 1, showing that actin is especially important in the
release of virus from the cell. We also noted that all of the
microtubule inhibitors group together with values near or
below 1, showing that microtubules play an important role
in both processes but with a larger effect on the production
of cell-associated virus.
Disruption of the cytoskeleton does not affect the ability of
RSV to accomplish proper transcription of its genes
In the previous studies, we showed that the cytoskeletal
inhibitors caused a block in RSV viral production in the
cell-associated fractions. We sought to determine if the virus
was blocked at the replication or transcription step of its life
cycle, when the cytoskeleton was altered. To fully test this,
we examined by real-time quantitative RT-PCR assays the
ability of RSV to transcribe two different viral genes, N and
F. The cells were infected with RSV at a high or low MOI
and then treated with an inhibitor for actin or microtubules
or with solvent alone. After 1 day, total RNA was extracted
from cell lysates and assayed for level of RSV N or F RNA,
and also a cellular housekeeping gene GADPH to control
for amount of RNA loaded into the assay. To test for the
amount of viral RNA, we used gene-specific probes that had
been previously described to be sensitive and specific for
the N and F genes of RSV wild-type strain A2 (Hu et al.,
2003; Mentel et al., 2003). The level of transcription of the
cellular housekeeping gene GADPH was also used to
control for any sample-to-sample variation in the RNA
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the experiments, the standard deviation within sample
batches was at the greatest only F0.604, and signal for
RSV RNA was never detected in negative controls (results
not shown). The amount of RSV transcription was
determined by the cycle number at which the amount of
fluorescence reached 10 standard deviations over the back-
ground (designated the CT). To determine the level of RSV
RNA, we normalized the results from each sample by
subtracting the CT of the GADPH assay from the RSV
specific CT value to arrive at the DCT (Table 3). To
determine the effect the cytoskeleton inhibitors had upon
RSV RNA levels, the DCT values of the inhibitor-treated
samples were subtracted from the DCT values in the
presence of solvent alone to yield a DDCT value. To
understand the significance of these values more intuitively,
we converted the DDCT values to fold difference, as shown
in Table 3. These results showed that there was very little
difference between the inhibitor-treated samples and those
treated with solvent alone. None of the samples showed a
difference of RSV RNA level more than 2-fold, which is the
limit of detection of this assay.
Actin polymerization inhibitors differ in effect on local
spread of virus and cell-to-cell fusion
Next, we examined the role of the cytoskeleton on the
spread of virus, which is essential to a robust infection in
culture. RSV causes distinct changes in the morphology of
HEp-2 cells during spread in culture, which occurs by the
local spread of infectious viral particles to surrounding cells
and by the fusion of cell membranes, creating multi-
nucleated giant cells in a formation designated a syncytium.
Using the RSV-GFP virus, we visualized the number and
morphology of live infected cells during disruption of the
functional elements of cytoskeleton. The inhibitors medi-
ated varying degrees of inhibition of local spread and cell-
to-cell fusion. Of interest was the difference observedTable 3
RNA level of RSV N or F protein genes in inflected cells is not affected signific
Treatment RSV N gene RNA level
MOIa 0.3 MOI 8
DCT
b DDCT
c Fold
changed
DCT DDCT Fo
cha
Solvent only 0.44 F 0.22 0.00 1.0 2.76 F 0.20 0.00 1.0
Latrunculin A 0.43 F 0.25 0.01 1.0 3.36 F 0.24 0.60 1.5
Cytochalasin D 0.20 F 0.27 0.23 1.2 3.19 F 0.20 0.43 1.4
Jasplakinolide 0.17 F 0.27 0.27 1.2 3.67 F 0.16 0.91 1.9
Nocodazole 0.47 F 0.19 0.03 1.0 3.19 F 0.14 0.43 1.4
Paclitaxel 0.27 F 0.41 0.17 1.1 3.39 F 0.22 0.63 1.6
a Multiplicity of infection.
b The CT is the cycle threshold at which the fluorescence reaches 10 standard dev
cellular control gene GADPH CT values from the viral RNA CT values for each
c The DDCT is difference of change between virus RNAwith the inhibitors and w
DCT value in the presence of each of the inhibitors.
d The fold change is determined by the equation 2DDCT.between the effect of two actin inhibitors latrunculin A and
cytochalasin D on the local spread during productive viral
infection (Fig. 3). Both of these inhibitors are actin filament
destabilizers, but they differ in their mode of action.
Latrunculin A binds to G-actin, the monomeric form, and
sequesters it from the formation of filaments, whereas
cytochalasin D binds to filaments directly and disrupts
filament formation (Spector et al., 1999). Under conditions
of a low M.O.I., by day 2 post-infection we observed large
foci of virus-infected cells and syncytium formation incor-
porating large numbers of cells within these foci. These
syncytia continued to spread to the whole monolayer, causing
massive syncytium formation by day 3. With both the
latrunculin A and cytochalasin D treated cells, local spread
did not occur by day 2, and only single-cell foci were visible.
By day 3, a distinction was seen between the two inhibitors.
The cytochalasin D treatment continued to inhibit local
spread, as evidenced by the restriction to single cell foci, but
the latrunculin A treatment allowed clusters of infected but
unfused cells within foci, likely representing the local spread
of virus to neighboring cells. Surprisingly, syncytium
formation was not observed in either culture condition,
even when the latrunculin A treatment allowed infection of
cells in close proximity to each other. By day 4, cytocholasin
D and latrunculin A exhibited similar effects on local spread,
but no substantial syncytium formation was seen. These
results suggest that cell–cell fusion resulting in syncytium
formation requires actin filament formation, and that local
spread of virus does not require syncytium formation.Discussion
This study shows that the actin and microtubule networks
play several important roles in the growth and spread of
RSV in cell culture. We used a panel of cytoskeletal
inhibitors to determine the extent of the requirement for
cytoskeletal elements in viral growth and spread. We foundantly by treatment with cytoskeletal inhibitors
RSV F gene RNA level
MOI 0.3 MOI 8
ld
nge
DCT DDCT Fold
change
DCT DDCT Fold
change
0.24 F 0.22 0.00 1.0 3.80 F 0.06 0.00 1.0
0.15 F 0.20 0.09 0.9 4.69 F 0.07 0.89 1.9
0.16 F 0.12 0.08 1.0 4.24 F 0.08 0.44 1.4
0.11 F 0.19 0.13 0.9 4.48 F 0.34 0.68 1.6
0.32 F 0.15 0.08 1.1 4.11 F 0.11 0.31 1.2
0.33 F 0.30 0.10 1.1 4.16 F 0.09 0.36 1.3
iations above background values. The DCT is determined by subtracting the
sample.
ithout; it is determined by subtracting the DCT of the solvent alone from the
Fig. 3. Local spread of virus and cell-to-cell fusion of RSV-infected cells in HEp-2 monolayers when treated with cytochalasin D or latrunculin A. Cells that
were inhibitor-treated or mock-treated post-infection with RSV-GFP virus were viewed and representative images were acquired at 10 magnification using
epifluorescence on day 2 and day 3 post-infection. The mean number of cells per infectious focus are indicated in the inset.
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microtubule elements altered the efficiency of virus repli-
cation at every step within the viral life cycle that was
tested, from entry to viral spread, except for viral genome
replication and transcription.
We observed up to a 10-fold reduction of the efficiency
of viral entry and early replication when inhibitors were
present prior to viral infection. This inhibition of virus
infectivity, as measured by reduction of RSV-GFP fluores-
cent foci, could either be occurring at the stage of entry of
virus into the cell or during the formation or function of the
transcriptional machinery. Quantitative RT-PCR studies
showed that there was no difference in the amount of
production of RSV RNA when the virus was grown in the
presence of inhibitors. Therefore, the entry of the virus is
most likely the stage of the virus life cycle that was affected
at early time points. Little is known about the mechanism of
fusion of the RSV envelope with the cellular envelope but it
is probable that this process requires the proper function of
the cytoskeletal network.
We also sought to determine what effect the inhibitors
would have on the later stages of assembly of virus within
the cell-associated fraction, and on the release of correctly
assembled virus from the cell. We found that both classes of
inhibitors had a large inhibitory effect on the release of virus
from the cell. The actin inhibitors jasplakinolide and
cytochalasin D mediated up to 1000-fold reductions in viral
yield into the supernatant. This marked inhibition was
observed in studies conducted using either high or low
M.O.I. conditions, showing that the large reduction
observed was not exaggerated by a cumulative effect duringmultiple rounds of replication. In experiments designed to
determine the inhibitory effect on virus assembly occurring
in the cell fraction prior to release, we observed that
treatment with the microtubule inhibitors nocodazole and
paclitaxel resulted in the most dramatic reduction of viral
yield. Interestingly, virus assembly in the presence of
latrunculin A was not significantly different than that in
the absence of inhibitor, despite major morphological
changes in the cells. These studies demonstrate that proper
formation and function of both actin and microtubules
contributes to virus assembly and release. The relative
magnitude of inhibition shows that microtubule filaments
play a greater role in the assembly of the virus, as measured
by formation of virus in the cell fraction, whereas actin
filaments principally facilitate the release of RSV.
Previous investigators have demonstrated a requirement
for either microtubules or actin during in vitro transcription
and replication of some paramyxoviruses (De et al., 1993;
Moyer et al., 1990). In vitro replication of RSV was shown
to require actin but not microtubules (Burke et al., 1998). It
is a possibility that the cytoskeletal network is involved in a
direct interaction with the viral replication machinery, as
suggested by previous in vitro transcription work, or that
microtubules and actin provide an organizing support or
scaffolding mechanism for the assembly of virus transcrip-
tional complexes. To address this, we looked at the ability of
RSV to efficiently replicate and transcribe the viral genome
in the presence of the inhibitors. Our quantitative studies of
the level of RSV RNA in infected cells showed no effect of
the inhibitors on the level of RNA produced. These results
do not necessarily contradict previous in vitro data suggest-
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necessary for transcription. Our results do suggest, however,
that polymerized cytoskeleton is not necessary for organiz-
ing a complex for transcription in cells. RSV must
accomplish virus spread within the respiratory tract follow-
ing inoculation in order to establish a productive infection.
We suggest that RSV spreads in HEp-2 cell monolayer
culture by two principal independent mechanisms (1) local
spread of budded virus to uninfected cells within close
proximity and (2) spread through the fusion of infected cells
to adjacent uninfected cells creating a syncytium. We
observed that both actin inhibitors tested completely
prevented syncytium formation. We also noted that there
was a marked difference between the actin inhibitors in
potency for inhibition of local spread. The cytochalasin D
treatment completely inhibited local spread to uninfected
cells, whereas latrunculin A treated cells showed a rosette of
infected neighboring cells late in infection, suggesting local
spread in the absence of syncytium formation at day 3.
These two inhibitors destabilize actin filaments through
different mechanisms. Latrunculin A depletes the G-actin
stores used to make or repair actin filaments, while
cytochalasin D disrupts the filament directly (Spector et
al., 1999). These findings are particularly interesting
because they show that (1) actin filaments are required for
syncytium formation, (2) decreasing the availability of G-
actin to make actin filaments is less important to the local
spread of RSV in culture than the disruption of the filament
itself, and (3) the mechanisms underlying local spread of
virus and cell-to-cell fusion differ. Interestingly, this
phenomenon may be unique to RSV among the para-
myxoviruses. Previously, investigators looked at the effect
of latrunculin A on a related paramyxovirus, measles virus
(Berghall et al., 2004). Those studies showed that latruncu-
lin A did not inhibit the syncytium formation caused by
measles.
In summary, we studied the role of the cytoskeleton in
RSV replication and found that the two major components
of the cytoskeleton, microtubules and actin, are required for
virus entry and early replication, cell-associated processes
resulting in virus assembly, release of the virus, and
syncytium formation.Materials and methods
Cells and viruses
HEp-2 cell monolayer cultures were maintained in Opti-
MEM I medium (Life Technologies) supplemented with
glutamine, gentamicin, amphotericin B, and 2% fetal bovine
serum. RSV wild-type strain A2 was previously described
(Coates et al., 1966). A green fluorescent protein (GFP)
expressing RSV was described previously and kindly
provided by Mark Peeples and Peter Collins (Hallak et al.,
2000). Working suspensions of viruses were prepared bypropagating virus in HEp-2 cell monolayer cultures until
cultures exhibited significant cytopathic effect. The virus-
infected cell culture supernatant and cell fractions were
collected, and cellular debris was removed by centrifugation
for 20 min at 2000  g. Virus-containing supernatant was
collected, frozen in 1-ml aliquots, and stored at 80 8C until
use.
Inhibitors
Cytochalasin D (Sigma catalog # C-8273) was recon-
stituted in ethanol to a concentration of 2 mg/ml and stored
at 20 8C. Jasplakinolide (Molecular Probes, catalog # J-
7473) was reconstituted in methanol to a concentration of 1
mg/ml and stored at 20 8C. Latrunculin A (Biomol,
catalog # T-119) was reconstituted with ethanol to a
concentration of 1 mg/ml. The microtubule inhibitor
nocodazole (Sigma, catalog #M-1404) was reconstituted
with DMSO to a concentration of 10 mg/ml. Lastly,
paclitaxel (Sigma, catalog #T-7402) was reconstituted in
ethanol to a concentration of 25 mg/ml. All inhibitors were
tested in preliminary experiments to determine an appro-
priate working concentration to use in experiments. We
sought to identify the amount of inhibitor that caused a
majority of cells to be affected by the inhibitor, as measured
by a distinctive change in cellular morphology, with the
least amount of toxicity. Toxicity was measured by treating
HEp-2 cell monolayer cultures with varying concentrations
of inhibitor for 3 days. Each day, the cells that had been
released into the supernatant and trypsin-released adherent
cells were collected. Cell samples were then collected by
centrifugation at 1400  g and resuspended in equal
volumes. Samples were stained with trypan blue, and live/
dead cells counts were preformed separately with a
hemocytometer. The optimal concentrations of inhibitors
that were determined and used in the experiments are listed
in Table 1.
Studies of the effect of inhibitors on entry and early
replication events
HEp-2 cell monolayer cultures were grown to 90%
confluence on 96-well tissue culture plates. Monolayers
were incubated for 3, 6, or 12 h in medium containing either
the desired concentrations of inhibitors or solvent only.
After incubation, the inhibitor medium was removed and
replicate cell monolayer cultures were infected with RSV-
GFP using 10-fold dilutions of virus in medium or with
inhibitors, and virus was allowed to adsorb for 1 h at 37 8C.
All wells were washed with medium, and fresh medium
containing either inhibitor or solvent alone was added. All
infected cultures were incubated at 37 8C in 5% CO2. After
14 h, infected cells were visualized with a Nikon TE300
microscope using epifluorescence. The virus titer under
these conditions was determined using a fluorescent focus
assay, and these values were expressed as the number of
N.L. Kallewaard et al. / Virology 331 (2005) 73–8180infected cells per milliliter as previously described (Shaw et
al., 1985). Briefly, the number of infected cells/ml was
calculated by counting all of the fluorescent foci in one
sweep across each well of the 96-well plate using a 10
objective. This number of foci was multiplied by 2.8, which
accounts for the remainder of the well that was not counted
and then multiplied by the dilution of virus that was
inoculated. This infectious focus number was then
expressed as fluorescent focus units/ml (ffu/ml). The
average value of duplicate samples is shown in Table 2.
Photomicrographs of representative fluorescent foci show-
ing infected cell morphology or syncytium formation were
obtained at the same positions at 1, 2, or 3 days post-
infection. Representative photomicrographs were then used
to count the number of cells per fluorescent focus, as
indicated in Fig. 3.
Studies to determine the inhibitor effect on RSV yield when
inhibitor was added after viral entry
HEp-2 cell monolayer cultures at 90% confluence were
inoculated with RSV strain A2 at a multiplicity of infection
(M.O.I.) of 0.3 or 8 for 1 h at 37 8C. Cells were washed and
medium with inhibitors or solvent was added. Supernatant
and cell fractions were collected separately at 1, 2, or 3 days
post-infection. The supernatant was frozen immediately in
cryovials, while the cell-associated fractions were subjected
to three freeze/thaw cycles to disrupt cells and release virus,
and then stored at 80 8C until analysis. After all samples
were collected, the viral titer of each sample was determined
in duplicate by virus plaque assay in HEp-2 cell monolayer
cultures as described (Crowe et al., 1994). End-point titers
were calculated as log10 pfu/ml and the mean and standard
deviation of the reduction mediated by each inhibitor was
calculated.
Quantitative assay for RSV RNA
HEp-2 cell monolayer cultures at 90% confluence were
inoculated with RSV strain A2 at a M.O.I. of 0.3 or 8, or
were mock infected, for 1 h at 37 8C. Cells were washed and
medium with inhibitors or solvent was added. Supernatant
and cell fractions were collected 24 h post-infection. Cells
and cell debris were pelleted, and media removed and
discarded. The cell pellet was washed with PBS and then
cells were lysed with RNeasy RLT buffer according to the
manufacturer’s instructions, and frozen at 80 8C. Total
RNA was extracted using the RNeasy kit (Qiagen) accord-
ing to the manufacturer’s instructions along with the
additional step of DNAse digestion to rid the sample of
DNA prior to the RT-PCR. In a two-step RT-PCR assay, 50
Al RNA was transcribed using the High Capacity cDNA
Archive kit (ABI) according to the manufacturer’s instruc-
tions. In brief, the RT conditions were 10 min at 25 8C, 2 h
at 37 8C, and then a 4 8C hold. The resulting cDNA product
was then stored at 4 8C briefly until the real-time PCR assaywas performed. The cDNA was used in three separate
identical reactions to determine the level of RSV cDNA for
the RSV N or F genes, or for the cellular housekeeping gene
GAPDH as a RNA control. Both the N and F gene PCR
primers were synthesized by Invitrogen and reconstituted to
a 200 AM concentration, and N and F gene specific Taqman
probes were synthesized by Applied Biosystems and were
labeled with 6-FAM. The GAPDH primers and probes were
supplied by Applied Biosystems (Assays-On-Demand) and
were also 6-FAM labeled and were used as directed by the
manufacturer. The sequences of the primers and probes for
the N protein were previously described (Hu et al., 2003)
and were used at 0.5 AM for each primer and 0.2 AM
concentration for the N probe. F protein primers and probe
sequences were previously described (Mentel et al., 2003),
and were used at concentrations of 0.3 AM of primers, and
0.1 AM of the probe. Amplification was carried out using
Omnimix HS beads (Takara, Fischer Scientific), one bead
for 2  25 Al reactions. Each bead was reconstituted in a 50
Al volume including 15 Al of cDNA, and the primers and
probes. Each of the triplicate infected cell lysate samples
was assayed in duplicate quantitative RT-PCR assays for
RNA level of the RSV N, F, or cellular GADPH genes. The
reaction was carried out using the Smart Cycler II (Cepheid)
with 1 cycle for 2 min at 50 8C and 10 min at 95 8C,
followed by up to 30 cycles of 15 s at 95 8C, or stopping
automatically five cycles after the fluorescence reached the
cycle threshold (CT). During amplification, the detector
monitored fluorescence emissions at every thermal cycle.
The CT was determined automatically by the cycler when
the signal achieved a level that was 10 standard deviations
above the background level of fluorescence. Standard
precautions were taken throughout the RT-PCR process to
avoid cross-contamination. Negative controls and a solvent
control were included for each of the inhibitor concen-
trations. The CT values for the cellular control gene GADPH
were subtracted from the RNA CT values to arrive at the
cycle number difference in transcription designated the DCT.
The average of DCT values was determined for the triplicate
samples, and these numbers for each inhibitor at each
M.O.I. were compared to the DCT values for solvent alone.
The difference of change between virus RNA levels with the
inhibitors and without was calculated by subtracting the
DCT of the sample treated with solvent alone from the DCT
value in the presence of each of the inhibitors, which
yielded a DDCT value. For ease of interpretation, these
values were converted into fold differences by using the
equation of 2DDCT (Table 3).Acknowledgments
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